We report the results from a post hoc analysis of a @-week dose optimization phase from a large randomized , placebo-controlled , multicenter @-week study ( @-week double-blind dose confirmation phase , @-week open-label dose optimization phase , and @-week double-blind maintenance of effect phase ) .